Related Experiment Video
Updated: Jan 8, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Diagnosis and treatment of familial hypercholesterolaemia
G Kees Hovingh1, Michael H Davidson, John J P Kastelein
1Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room F4-159.2, 1105 AZ Amsterdam, The Netherlands.
Insights
Familial hypercholesterolaemia (FH) is a genetic disorder causing high LDL-C. Early diagnosis and new treatments are crucial for preventing cardiovascular disease in FH patients.
Area of Science:
- Cardiovascular Genetics
- Pharmacotherapy
Background:
- Familial hypercholesterolaemia (FH) is an autosomal dominant disorder characterized by elevated low-density lipoprotein-cholesterol (LDL-C).
- High LDL-C levels significantly increase the risk of premature cardiovascular disease, emphasizing the need for early diagnosis and intervention.
- Current diagnostic methods include clinical assessment and genetic testing, with a focus on reducing LDL-C levels to prevent morbidity and mortality.
Purpose of the Study:
- To review current and emerging treatment strategies for managing Familial hypercholesterolaemia.
- To discuss the diagnostic approaches for FH, including clinical and genetic testing.
- To highlight the importance of achieving target LDL-C levels in FH patients.
Main Methods:
- Review of current literature on FH diagnosis and treatment.
- Analysis of existing guidelines for LDL-C management in FH.
- Exploration of novel pharmacotherapies targeting LDL-C metabolism.
Main Results:
- Statins are the standard treatment but many FH patients do not reach target LDL-C levels.
- New drug classes are under investigation, including agents inhibiting apolipoprotein B and pro-protein convertase subtilisin/kexin 9 (PCSK9).
- Therapies aimed at increasing high-density lipoprotein cholesterol are also being evaluated.
Conclusions:
- Effective management of FH requires a multi-faceted approach including early diagnosis and aggressive LDL-C lowering.
- Novel therapeutic agents show promise in improving LDL-C control beyond current standards.
- Continued research into FH treatment is essential to reduce the cardiovascular burden associated with this genetic disorder.
Abstract:
Familial hypercholesterolaemia (FH) is an autosomal dominant genetic disorder, associated with elevated levels of low-density lipoprotein-cholesterol (LDL-C), which can lead to premature cardiovascular disease. Early diagnosis of FH is important to prevent morbidity and mortality. Familial hypercholesterolaemia is usually diagnosed using clinical characteristics, such as family history, and cholesterol levels; however, genetic testing may provide a definite diagnosis of FH by detecting a pathological mutation. Current guidelines highlight the importance of reducing LDL-C levels in patients with FH. Statins are the current standard treatment for the majority of these patients, and have been shown to be effective in reducing the incidence of cardiovascular heart disease in patients with FH. Nevertheless, many FH patients do not achieve their target LDL-C levels; as such, new treatment options are required to decrease LDL-C levels beyond those currently achieved. There are currently several new classes of pharmacotherapy under investigation to control LDL-C levels. These include agents which modify LDL-C production, such as inhibitors of apolipoprotein B, or those which affect LDL-C catabolism, such as inhibition of pro-protein convertase subtilisin/kexin 9, a protein which is responsible for the degradation of the LDL receptor. Therapies which raise high-density lipoprotein cholesterol are also being evaluated. In this article, we consider the diagnosis of FH and the goals of therapy and review the current and potential future treatment options for patients with FH.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements

